Female Health ROE 2006-2018 | VERU

Current and historical return on equity (ROE) values for Female Health (VERU) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Female Health ROE for the three months ending December 31, 2018 was -60.83%.
Female Health ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-12-31 $-0.02B $0.04B -61.54%
2018-09-30 $-0.02B $0.03B -63.58%
2018-06-30 $-0.02B $0.04B -49.41%
2018-03-31 $-0.01B $0.04B -30.27%
2017-12-31 $-0.01B $0.05B -24.49%
2017-09-30 $-0.01B $0.05B -17.65%
2017-06-30 $-0.01B $0.05B -12.63%
2017-03-31 $-0.00B $0.05B -9.14%
2016-12-31 $-0.00B $0.05B -5.06%
2016-09-30 $0.00B $0.03B 0.00%
2016-06-30 $0.00B $0.04B 8.63%
2016-03-31 $0.00B $0.04B 8.89%
2015-12-31 $0.01B $0.04B 15.27%
2015-09-30 $0.01B $0.03B 16.00%
2015-06-30 $0.00B $0.03B 10.00%
2015-03-31 $0.00B $0.03B 10.26%
2014-12-31 $0.00B $0.03B 3.51%
2014-09-30 $0.00B $0.03B 3.51%
2014-06-30 $0.01B $0.03B 30.77%
2014-03-31 $0.01B $0.03B 31.30%
2013-12-31 $0.01B $0.03B 42.48%
2013-09-30 $0.02B $0.03B 55.56%
2013-06-30 $0.02B $0.03B 63.37%
2013-03-31 $0.02B $0.03B 76.60%
2012-12-31 $0.02B $0.02B 80.00%
2012-09-30 $0.02B $0.02B 82.05%
2012-06-30 $0.01B $0.02B 73.24%
2012-03-31 $0.01B $0.02B 62.50%
2011-12-31 $0.01B $0.02B 52.46%
2011-09-30 $0.01B $0.02B 33.90%
2011-06-30 $0.01B $0.01B 41.38%
2011-03-31 $0.01B $0.01B 42.11%
2010-12-31 $0.01B $0.02B 58.18%
2010-09-30 $0.01B $0.02B 53.85%
2010-06-30 $0.00B $0.01B 24.49%
2010-03-31 $0.00B $0.01B 33.33%
2009-12-31 $0.00B $0.01B 34.78%
2009-09-30 $0.01B $0.01B 65.12%
2009-06-30 $0.01B $0.01B 70.00%
2009-03-31 $0.01B $0.01B 73.68%
2008-12-31 $0.01B $0.01B 64.86%
2008-09-30 $0.01B $0.01B 55.56%
2008-06-30 $0.00B $0.01B 48.48%
2008-03-31 $0.00B $0.01B 40.00%
2007-12-31 $0.00B $0.01B 29.63%
2007-09-30 $0.00B $0.01B 16.67%
2007-06-30 $0.00B $0.01B 0.00%
2007-03-31 $0.00B $0.01B 0.00%
2006-12-31 $0.00B $0.01B 0.00%
2006-09-30 $0.00B $0.01B 0.00%
2006-06-30 $0.00B $0.00B 0.00%
2006-03-31 $0.00B $0.00B 0.00%
2005-12-31 $0.00B $0.00B 0.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.088B $0.016B
Veru Inc. engages in the development, manufacture and marketing of consumer health care products. It focuses on producing FC2 female condom which provides dual protection against unintended pregnancy and sexually transmitted infections. Veru Inc., formerly known as The Female Health Company, is headquartered in Miami, FL.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $133.667B 26.06
Medtronic (MDT) Ireland $114.132B 16.69
Stryker (SYK) United States $69.756B 24.90
Boston Scientific (BSX) United States $49.905B 24.25
Baxter (BAX) United States $39.019B 25.03
Zimmer Biomet Holdings (ZBH) United States $25.114B 16.07
Smith & Nephew SNATS (SNN) United Kingdom $16.786B 0.00
Canopy Growth (CGC) Canada $16.315B 0.00
ResMed (RMD) United States $14.544B 27.58
Aurora Cannabis (ACB) Canada $9.179B 64.71
Bio-Rad Laboratories (BIO) United States $8.795B 50.45
Perrigo (PRGO) Ireland $6.734B 10.92
Hill-Rom Holdings (HRC) United States $6.397B 19.79
GW Pharmaceuticals (GWPH) United Kingdom $4.994B 0.00
Insulet (PODD) United States $4.964B 1664.20
ICU Medical (ICUI) United States $4.636B 28.71
Haemonetics (HAE) United States $4.354B 38.62
Hutchison China MediTech (HCM) China $3.962B 0.00
Agios Pharmaceuticals (AGIO) United States $3.443B 0.00
Neogen (NEOG) United States $3.004B 48.85
NuVasive (NUVA) United States $2.967B 25.77
Quidel (QDEL) United States $2.487B 22.25
National Vision Holdings (EYE) United States $2.276B 44.77
Aphria (APHA) $1.957B 0.00
HEXO (HEXO) $1.474B 0.00
Phibro Animal Health (PAHC) United States $1.338B 19.24
VAREX IMAGING (VREX) United States $1.234B 24.16
Cardiovascular Systems (CSII) United States $1.212B 870.25
AtriCure (ATRC) United States $1.076B 0.00
Lantheus Holdings (LNTH) United States $0.957B 25.86
Omeros (OMER) United States $0.929B 0.00
PetIQ (PETQ) United States $0.865B 24.76
Cerus (CERS) United States $0.831B 0.00
MacroGenics (MGNX) United States $0.820B 0.00
NanoString Technologies (NSTG) United States $0.781B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.725B 24.66
TG Therapeutics (TGTX) United States $0.717B 0.00
Evolus (EOLS) United States $0.708B 0.00
OraSure Technologies (OSUR) United States $0.589B 25.68
Surmodics (SRDX) United States $0.584B 84.94
LeMaitre Vascular (LMAT) United States $0.555B 26.37
Meridian Bioscience (VIVO) United States $0.538B 16.02
Quanterix (QTRX) United States $0.515B 0.00
Insys Therapeutics (INSY) United States $0.332B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.329B 0.00
Utah Medical Products (UTMD) United States $0.326B 21.19
BioLife Solutions (BLFS) United States $0.302B 124.61
Vapotherm (VAPO) United States $0.287B 0.00
Rockwell Medical (RMTI) United States $0.270B 0.00
Cytosorbents (CTSO) United States $0.228B 0.00
Owens & Minor (OMI) United States $0.213B 2.91
Zynex (ZYXI) United States $0.172B 18.38
Bovie Medical (APYX) United States $0.140B 0.00
Chimerix (CMRX) United States $0.138B 0.00
Fonar (FONR) United States $0.128B 6.85
Chembio Diagnostics (CEMI) United States $0.122B 0.00
Surface Oncology (SURF) United States $0.114B 0.00
United-Guardian (UG) United States $0.089B 20.32
InfuSystems Holdings (INFU) United States $0.085B 0.00
Neurotrope (NTRP) United States $0.075B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.069B 0.00
Trinity Biotech (TRIB) Ireland $0.067B 19.86
GUARDION HEALTH (GHSI) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.045B 0.00
Senestech (SNES) United States $0.036B 0.00
Valeritas Holdings (VLRX) United States $0.031B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.024B 0.00
Myomo (MYO) United States $0.021B 0.00
Capricor Therapeutics (CAPR) United States $0.017B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Akers Biosciences Inc (AKER) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.007B 13.00